Clinical Trials · NCT05390892
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Brigham and Women's Hospital
- Enrollment
- 6,000
- Start date
- Sep 2022
- Locations
- 36 sites, United States
- Primary endpoint
- Total (first and recurrent) cardiovascular, kidney, and death events